Article
p53 mutant-type in human prostate cancer cells determines the sensitivity to phenethyl isothiocyanate induced growth inhibition.
Journal of experimental & clinical cancer research : CR - 15 Jul 2019
Aggarwal Monika, Saxena Rahul, Asif Nasir, Sinclair Elizabeth, Tan Judy, Cruz Idalia, Berry Deborah, Kallakury Bhaskar, Pham Quynhchi, Wang Thomas T Y, Chung Fung-Lung
Abstract excerpt
BACKGROUND: We reported previously that phenethyl isothiocyanate (PEITC), a dietary compound, can reactivate p53R175H mutant in vitro and in SK-BR-3 (p53R175H) breast xenograft model resulting in tumor inhibition. Because of the diversity of human cancers with p53 mutations, these findings raise important questions whether this mechanism operates in different cancer types with same or different p53 mutations. In...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
